David S Liebeskind, MD, MBA is an expert in Neurology at University of California, Los Angeles (United States). As of October 2026, ScienceLeadR ranks David S Liebeskind in the top 1% of experts worldwide for Cerebrovascular Disorders, Brain Ischemia and Brain Infarction. David S Liebeskind has authored 1,593 publications, the most recent in 2026, and is an investigator in 74 clinical trials, 5 of them ongoing. SLR score: 6,030 (community average: 125). How the SLR is computed.

LeadR Profile

David S Liebeskind, MD, MBA University of California, Los Angeles United States
6 030 ScienceLeadR Reputation 6030
Network Map

Neurology

Subspecialties: Cardiology - Medical Imaging - Surgery

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2000 - 2026

Source: PubMed

University of Southern California

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 1593

Citations

Citations: 61 651 1st author: 136 Last author: 248 Unique author: 96


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Revascularization in Asymptomatic Carotid Artery Stenosis With Hemodynamic Impairment and Cognitive Outcomes: The CREST-H Substudy of the CREST-2 Randomized Clinical Trial.
PMID 42747834 — constriction, pathologic, carotid arteries, carotid stenosis, cognitive dysfunction, arteries, therapeutics, cognition, hemodynamics
JAMA Top journal20261
Deterioration of Peri-Infarct Microvascular Hemodynamics Following Successful Reperfusion in Acute Ischemic Stroke Predicts Infarct Growth.
PMID 42803008 — growth, ischemic stroke, stroke, odds ratio, reperfusion, thrombectomy, hemodynamics, no-reflow phenomenon
Stroke20260
Cerebral No-Reflow after Thrombectomy: International Delphi Consensus on Definition and Imaging Assessment.
PMID 42861924 — reperfusion, thrombectomy
Ann Neurol20260
Neuropsychiatric Symptom Associations with NOTCH3 Genotype in the United States CADASIL Consortium.
PMID 42856679 — cadasil, signs and symptoms, genotype
medRxiv20260
Adjuvant Systemic Hypothermia During Mechanical Thrombectomy (ReCCLAIM II): A Multicenter, Randomized, Controlled Trial.
PMID 42852505 — ischemic stroke, stroke, arteries, drug-related side effects and adverse reactions, cerebrovascular circulation, reperfusion, hypothermia, cerebrovascular disorders, therapeutics, punctures, cerebral infarction, thrombectomy, temperature
Stroke20260

Clinical Studies 74

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 5 Study Director: 1

By phase:

N/A 45
Phase 3 17
Phase 2 3
Phase 4 3
Phase 1 2
Phase 2/Phase 3 2
Early Phase 1 1
Phase 1/Phase 2 1

By status:

Completed 55
Terminated 8
Recruiting 4
Unknown 3
Enrolling by invitation 2
Active not recruiting 1
Withdrawn 1

By type:

Interventional 54
Observational 20

By Monocentric/Multicentric:

monocentric 25
multicentric2to4 6
multicentric5to9 6
multicentricup10 37

Main Topics

Cohort/Consortium Investigators 4

Ongoing Clinical Trials

5 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Cardiac Abnormalities in Stroke Prevention and Risk of Recurrence
NCT06398366 — ischemic stroke, stroke, heart failure, heart, multiple chronic conditions, cohort studies, atherosclerosis, embolic stroke, cardiomyopathies
N/AEnrolling by invitation2022
International Post Stroke Epilepsy Research Repository
NCT06108102 — epilepsy, stroke, neuroimaging, hemorrhagic stroke, seizures, diagnosis, research, prognosis
N/AEnrolling by invitation2024
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Study
NCT05677880 — dementia, blood, cognitive dysfunction, cadasil, dementia, vascular, leukoencephalopathies, cognition disorders, nerve degeneration, self report
N/ARecruiting2022
Intra arterial Recombinant Human TNK Tissue type Plasminogen Activator (rhTNK tPA) Thrombolysis for Acute Large Vascular Occlusion After Successful Mechanical Thrombectomy Recanalization
NCT05624190 — ischemic stroke, stroke, plasminogen, plasminogen activators, tissue plasminogen activator, tenecteplase, tissues, thrombectomy
Phase 4Recruiting2023
Platelet Expression of Fc RIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
NCT05518305 — ischemic stroke, stroke, magnetic resonance imaging, diagnostic imaging, atherosclerosis, blood platelets, ischemia, hemodynamics
N/ARecruiting2022

LeadR Networks

Main global connection map